BlackRock’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $164M | Buy |
|
|||||
|
2023
Q1 | $91.3M | Sell |
|
|||||
|
2022
Q4 | $104M | Buy |
|
|||||
|
2022
Q3 | $71.8M | Buy |
|
|||||
|
2022
Q2 | $58.3M | Buy |
|
|||||
|
2022
Q1 | $50M | Buy |
|
|||||
|
2021
Q4 | $48.7M | Buy |
|
|||||
|
2021
Q3 | $32.4M | Buy |
|
|||||
|
2021
Q2 | $34.9M | Buy |
|
|||||
|
2021
Q1 | $21.9M | Sell |
|
|||||
|
2020
Q4 | $22.3M | Buy |
|
|||||
|
2020
Q3 | $10.7M | Sell |
|
|||||
|
2020
Q2 | $10.4M | Buy |
|
|||||
|
2020
Q1 | $11.9M | Sell |
|
|||||
|
2019
Q4 | $5.15M | Sell |
|
|||||
|
2019
Q3 | $5.62M | Buy |
|
|||||
|
2019
Q2 | $8.05M | Buy |
|
|||||
|
2019
Q1 | $19.9M | Sell |
|
|||||
|
2018
Q4 | $14.1M | Buy |
|
|||||
|
2018
Q3 | $37.6M | Buy |
|
|||||
|
2018
Q2 | $32.9M | Buy |
|
|||||
|
2018
Q1 | $33M | Sell |
|
|||||
|
2017
Q4 | $27M | Sell |
|
|||||
|
2017
Q3 | $39M | Buy |
|
|||||
|
2017
Q2 | $38.7M | Buy |
|
|||||
|
2017
Q1 | $34M | Buy |
|
|||||
|
2016
Q4 | $45K | Sell |
|
|||||
|
2016
Q3 | $181K | Buy |
|
|||||
|
2016
Q2 | $142K | Buy |
|
|||||
|
2016
Q1 | $8K | Buy |
|
|||||
|
2015
Q4 | $5K | Hold |
|
|||||
|
2015
Q3 | $4K | Hold |
|
|||||
|
2015
Q2 | $6K | Buy |
|